Literature DB >> 2043717

The analysis of 5-fluorouracil in human plasma by gas chromatography-negative ion chemical ionization mass spectrometry (GC-NICIMS) with stable isotope dilution.

C D Bates1, D G Watson, N Willmott, H Logan, J Goldberg.   

Abstract

5-Fluorouracil (5-FU) was extracted from plasma and converted to its di-N-ditrifluoromethylbenzyl (DTFMBz) derivative by treatment with DTFMBzBr. Under negative ion chemical ionization (NICI) conditions the derivative yielded a mass spectrum in which most of the ion current was carried by the M(-)-DTFMBz ion (m/z 355). Selected ion monitoring enabled detection of this derivative in amounts less than 1 pg, and the practical limit of detection for 5-FU extracted from plasma was ca 400 pg ml-1. 5-FU was quantified by adding a fixed amount of [15N2]5-FU to samples of plasma before extraction, and comparing the ratio of the ions of m/z 355 and 357 against a calibration curve constructed over the concentration range under investigation. The method was used to measure the variation in the concentration of 5-FU with time during continuous infusion of the drug via three, different protocols in patients with hepatic tumour.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2043717     DOI: 10.1016/0731-7085(91)80231-w

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  5 in total

1.  Derivatization of 5-fluorouracil with 4-bromomethyl-7-methoxycoumarin for determination by liquid chromatography-mass spectrometry.

Authors:  K Wang; M Nano; T Mulligan; E D Bush; R W Edom
Journal:  J Am Soc Mass Spectrom       Date:  1998-09       Impact factor: 3.109

2.  Prolonged retention of high concentrations of 5-fluorouracil in human and murine tumors as compared with plasma.

Authors:  G J Peters; J Lankelma; R M Kok; P Noordhuis; C J van Groeningen; C L van der Wilt; S Meyer; H M Pinedo
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

Review 3.  A Critical Review on Clinical Application of Separation Techniques for Selective Recognition of Uracil and 5-Fluorouracil.

Authors:  Khushaboo Pandey; Rama Shankar Dubey; Bhim Bali Prasad
Journal:  Indian J Clin Biochem       Date:  2015-02-15

4.  Prolonged intraperitoneal infusion of 5-fluorouracil using a novel carrier solution.

Authors:  D J Kerr; A M Young; J P Neoptolemos; M Sherman; P Van-Geene; A Stanley; D Ferry; J W Dobbie; B Vincke; J Gilbert; D el Eini; N Dombros; G Fountzilas
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

5.  Pharmacokinetic study of 5-fluorouracil in a novel dialysate solution: a long-term intraperitoneal treatment approach for advanced colorectal carcinoma.

Authors:  C S McArdle; D J Kerr; P O'Gorman; H A Wotherspoon; H Warren; D Watson; B J Vinké; J W Dobbie; D I el Eini
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.